Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Tarp

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|February 15, 2008
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO RegistryM L Hetland, H M Lindegaard, A Hansen, et al.
Scandinavian Journal of Rheumatology|November 10, 1998
Treatment of rheumatoid arthritis with a peptide diet: a randomized, controlled trialS E Holst-Jensen, M Pfeiffer-Jensen, M Monsrud, et al.
Clinical and Experimental Rheumatology|January 26, 2012
Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritisT Ellingsen, I Hansen, J Thorsen, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)M L Hetland, J Unkerskov, T Ravn, et al.
Scandinavian Journal of Rheumatology|May 4, 2007
Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO databaseM Ostergaard, J Unkerskov, L Linde, et al.
Clinical Rheumatology|January 16, 1999
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsetsS Jacobsen, J Petersen, S Ullman, et al.
Clinical Rheumatology|January 16, 1999
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic valueS Jacobsen, J Petersen, S Ullman, et al.
Scandinavian Journal of Rheumatology|May 6, 1999
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosusS Jacobsen, J Petersen, S Ullman, et al.
Scandinavian Journal of Rheumatology|November 24, 1999
Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinineS Jacobsen, H Starklint, J Petersen, et al.
Scandinavian Journal of Immunology|October 10, 2017
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease ActivityS F Issa, A F Christensen, H M Lindegaard, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|February 15, 2008
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO RegistryM L Hetland, H M Lindegaard, A Hansen, et al.
Scandinavian Journal of Rheumatology|November 10, 1998
Treatment of rheumatoid arthritis with a peptide diet: a randomized, controlled trialS E Holst-Jensen, M Pfeiffer-Jensen, M Monsrud, et al.
Clinical and Experimental Rheumatology|January 26, 2012
Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritisT Ellingsen, I Hansen, J Thorsen, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)M L Hetland, J Unkerskov, T Ravn, et al.
Scandinavian Journal of Rheumatology|May 4, 2007
Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO databaseM Ostergaard, J Unkerskov, L Linde, et al.
Clinical Rheumatology|January 16, 1999
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsetsS Jacobsen, J Petersen, S Ullman, et al.
Clinical Rheumatology|January 16, 1999
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic valueS Jacobsen, J Petersen, S Ullman, et al.
Scandinavian Journal of Rheumatology|May 6, 1999
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosusS Jacobsen, J Petersen, S Ullman, et al.
Scandinavian Journal of Rheumatology|November 24, 1999
Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinineS Jacobsen, H Starklint, J Petersen, et al.
Scandinavian Journal of Immunology|October 10, 2017
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease ActivityS F Issa, A F Christensen, H M Lindegaard, et al.
Pageof 5